Frey UH - Search Results

1

The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer.

Frey UH, Eisenhardt A, Lümmen G, Rübben H, Jöckel KH, Schmid KW, Siffert W. Frey UH, et al. Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):871-7. doi: 10.1158/1055-9965.EPI-04-0720. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15824158

2

Interaction of the G protein beta 3 subunit T825 allele and the IRS-1 Arg972 variant in type 2 diabetes.

Rosskopf D, Frey U, Eckhardt S, Schmidt S, Ritz E, Hofmann S, Jaksch M, Müller N, Hüsing J, Siffert W, Jöcke KH. Rosskopf D, et al. Eur J Med Res. 2000 Nov 30;5(11):484-90. Eur J Med Res. 2000. PMID: 11121369

3

The human G protein beta4 subunit: gene structure, expression, Ggamma and effector interaction.

Rosskopf D, Nikula C, Manthey I, Joisten M, Frey U, Kohnen S, Siffert W. Rosskopf D, et al. FEBS Lett. 2003 Jun 5;544(1-3):27-32. doi: 10.1016/s0014-5793(03)00441-1. FEBS Lett. 2003. PMID: 12782285 Free article.

4

Cooperative effect of GNB3 825C>T and GPIIIa PI(A) polymorphisms in enhanced platelet aggregation.

Frey UH, Aral N, Müller N, Siffert W. Frey UH, et al. Thromb Res. 2003 Mar 15;109(5-6):279-86. doi: 10.1016/s0049-3848(03)00253-6. Thromb Res. 2003. PMID: 12818251

5

Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism.

Hauner H, Meier M, Jöckel KH, Frey UH, Siffert W. Hauner H, et al. Among authors: frey uh. Pharmacogenetics. 2003 Aug;13(8):453-9. doi: 10.1097/00008571-200308000-00003. Pharmacogenetics. 2003. PMID: 12893983 Clinical Trial.

6

Successful amplification of extremely GC-rich promoter regions using a novel 'slowdown PCR' technique.

Bachmann HS, Siffert W, Frey UH. Bachmann HS, et al. Among authors: frey uh. Pharmacogenetics. 2003 Dec;13(12):759-66. doi: 10.1097/00008571-200312000-00006. Pharmacogenetics. 2003. PMID: 14646694

7

The CC genotype of the C825T polymorphism of the G protein beta3 gene (GNB3) is associated with a high relapse rate in patients with chronic lymphocytic leukaemia.

Nückel H, Frey U, Aralh N, Dürig J, Dührsen U, Siffert W. Nückel H, et al. Leuk Lymphoma. 2003 Oct;44(10):1739-43. doi: 10.1080/1042819031000111017. Leuk Lymphoma. 2003. PMID: 14692527

8

1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome.

Nückel H, Frey UH, Dürig J, Dührsen U, Siffert W. Nückel H, et al. Among authors: frey uh. Eur J Haematol. 2004 Apr;72(4):259-63. doi: 10.1111/j.0902-4441.2003.00210.x. Eur J Haematol. 2004. PMID: 15089763

9

Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia.

Nückel H, Frey UH, Dürig J, Dührsen U, Siffert W. Nückel H, et al. Among authors: frey uh. Leukemia. 2004 Nov;18(11):1816-23. doi: 10.1038/sj.leu.2403484. Leukemia. 2004. PMID: 15385937

10

Quantification of allele-specific G-protein beta3 subunit mRNA transcripts in different human cells and tissues by Pyrosequencing.

Sun A, Ge J, Siffert W, Frey UH. Sun A, et al. Among authors: frey uh. Eur J Hum Genet. 2005 Mar;13(3):361-9. doi: 10.1038/sj.ejhg.5201334. Eur J Hum Genet. 2005. PMID: 15536475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters